Generation of retinal pigmented epithelium from iPSCs derived from the conjunctiva of donors with and without age related macular degeneration

Zhouhui Geng, Patrick J. Walsh, Vincent Truong, Caitlin Hill, Mara Ebeling, Rebecca J. Kapphahn, Sandra R. Montezuma, Ching Yuan, Heidi Roehrich, Deborah A. Ferrington, James R. Dutton

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Fidelity in pluripotent stem cell differentiation protocols is necessary for the therapeutic and commercial use of cells derived from embryonic and induced pluripotent stem cells. Recent advances in stem cell technology, especially the widespread availability of a range of chemically defined media, substrates and differentiation components, now allow the design and implementation of fully defined derivation and differentiation protocols intended for replication across multiple research and manufacturing locations. In this report we present an application of these criteria to the generation of retinal pigmented epithelium from iPSCs derived from the conjunctiva of donors with and without age related macular degeneration. Primary conjunctival cells from human donors aged 70-85 years were reprogrammed to derive multiple iPSC lines that were differentiated into functional RPE using a rapid and defined differentiation protocol. The combination of defined iPSC derivation and culture with a defined RPE differentiation protocol, reproducibly generated functional RPE from each donor without requiring protocol adjustments for each individual. This successful validation of a standardized, iPSC derivation and RPE differentiation process demonstrates a practical approach for applications requiring the cost-effective generation of RPE from multiple individuals such as drug testing, population studies or for therapies requiring patient-specific RPE derivations. In addition, conjunctival cells are identified as a practical source of somatic cells for deriving iPSCs from elderly individuals.

Original languageEnglish (US)
Article numbere0173575
JournalPloS one
Volume12
Issue number3
DOIs
StatePublished - Mar 2017

Fingerprint

conjunctiva
Conjunctiva
Macular Degeneration
Stem cells
epithelium
Epithelium
Tissue Donors
stem cells
therapeutics
cells
somatic cells
Induced Pluripotent Stem Cells
cell differentiation
Pluripotent Stem Cells
manufacturing
Therapeutic Uses
Availability
Cell Differentiation
drugs
Stem Cells

Cite this

Generation of retinal pigmented epithelium from iPSCs derived from the conjunctiva of donors with and without age related macular degeneration. / Geng, Zhouhui; Walsh, Patrick J.; Truong, Vincent; Hill, Caitlin; Ebeling, Mara; Kapphahn, Rebecca J.; Montezuma, Sandra R.; Yuan, Ching; Roehrich, Heidi; Ferrington, Deborah A.; Dutton, James R.

In: PloS one, Vol. 12, No. 3, e0173575, 03.2017.

Research output: Contribution to journalArticle

@article{199129d26d7d43c29eaa210dd9141c54,
title = "Generation of retinal pigmented epithelium from iPSCs derived from the conjunctiva of donors with and without age related macular degeneration",
abstract = "Fidelity in pluripotent stem cell differentiation protocols is necessary for the therapeutic and commercial use of cells derived from embryonic and induced pluripotent stem cells. Recent advances in stem cell technology, especially the widespread availability of a range of chemically defined media, substrates and differentiation components, now allow the design and implementation of fully defined derivation and differentiation protocols intended for replication across multiple research and manufacturing locations. In this report we present an application of these criteria to the generation of retinal pigmented epithelium from iPSCs derived from the conjunctiva of donors with and without age related macular degeneration. Primary conjunctival cells from human donors aged 70-85 years were reprogrammed to derive multiple iPSC lines that were differentiated into functional RPE using a rapid and defined differentiation protocol. The combination of defined iPSC derivation and culture with a defined RPE differentiation protocol, reproducibly generated functional RPE from each donor without requiring protocol adjustments for each individual. This successful validation of a standardized, iPSC derivation and RPE differentiation process demonstrates a practical approach for applications requiring the cost-effective generation of RPE from multiple individuals such as drug testing, population studies or for therapies requiring patient-specific RPE derivations. In addition, conjunctival cells are identified as a practical source of somatic cells for deriving iPSCs from elderly individuals.",
author = "Zhouhui Geng and Walsh, {Patrick J.} and Vincent Truong and Caitlin Hill and Mara Ebeling and Kapphahn, {Rebecca J.} and Montezuma, {Sandra R.} and Ching Yuan and Heidi Roehrich and Ferrington, {Deborah A.} and Dutton, {James R.}",
year = "2017",
month = "3",
doi = "10.1371/journal.pone.0173575",
language = "English (US)",
volume = "12",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "3",

}

TY - JOUR

T1 - Generation of retinal pigmented epithelium from iPSCs derived from the conjunctiva of donors with and without age related macular degeneration

AU - Geng, Zhouhui

AU - Walsh, Patrick J.

AU - Truong, Vincent

AU - Hill, Caitlin

AU - Ebeling, Mara

AU - Kapphahn, Rebecca J.

AU - Montezuma, Sandra R.

AU - Yuan, Ching

AU - Roehrich, Heidi

AU - Ferrington, Deborah A.

AU - Dutton, James R.

PY - 2017/3

Y1 - 2017/3

N2 - Fidelity in pluripotent stem cell differentiation protocols is necessary for the therapeutic and commercial use of cells derived from embryonic and induced pluripotent stem cells. Recent advances in stem cell technology, especially the widespread availability of a range of chemically defined media, substrates and differentiation components, now allow the design and implementation of fully defined derivation and differentiation protocols intended for replication across multiple research and manufacturing locations. In this report we present an application of these criteria to the generation of retinal pigmented epithelium from iPSCs derived from the conjunctiva of donors with and without age related macular degeneration. Primary conjunctival cells from human donors aged 70-85 years were reprogrammed to derive multiple iPSC lines that were differentiated into functional RPE using a rapid and defined differentiation protocol. The combination of defined iPSC derivation and culture with a defined RPE differentiation protocol, reproducibly generated functional RPE from each donor without requiring protocol adjustments for each individual. This successful validation of a standardized, iPSC derivation and RPE differentiation process demonstrates a practical approach for applications requiring the cost-effective generation of RPE from multiple individuals such as drug testing, population studies or for therapies requiring patient-specific RPE derivations. In addition, conjunctival cells are identified as a practical source of somatic cells for deriving iPSCs from elderly individuals.

AB - Fidelity in pluripotent stem cell differentiation protocols is necessary for the therapeutic and commercial use of cells derived from embryonic and induced pluripotent stem cells. Recent advances in stem cell technology, especially the widespread availability of a range of chemically defined media, substrates and differentiation components, now allow the design and implementation of fully defined derivation and differentiation protocols intended for replication across multiple research and manufacturing locations. In this report we present an application of these criteria to the generation of retinal pigmented epithelium from iPSCs derived from the conjunctiva of donors with and without age related macular degeneration. Primary conjunctival cells from human donors aged 70-85 years were reprogrammed to derive multiple iPSC lines that were differentiated into functional RPE using a rapid and defined differentiation protocol. The combination of defined iPSC derivation and culture with a defined RPE differentiation protocol, reproducibly generated functional RPE from each donor without requiring protocol adjustments for each individual. This successful validation of a standardized, iPSC derivation and RPE differentiation process demonstrates a practical approach for applications requiring the cost-effective generation of RPE from multiple individuals such as drug testing, population studies or for therapies requiring patient-specific RPE derivations. In addition, conjunctival cells are identified as a practical source of somatic cells for deriving iPSCs from elderly individuals.

UR - http://www.scopus.com/inward/record.url?scp=85015286996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015286996&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0173575

DO - 10.1371/journal.pone.0173575

M3 - Article

C2 - 28282420

AN - SCOPUS:85015286996

VL - 12

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 3

M1 - e0173575

ER -